Optiver Holding’s Trillium Therapeutics Inc. TRIL Stock Holding History

Optiver Holding’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,049	Closed	-$18K	–	965
2021 Q4	$18K	Hold	1,049	–	–	﹤0.01%	601
2021 Q3	$18K	Buy	+1,049	New	+$12.3K	﹤0.01%	480

Optiver Holding's TRIL Position: Q1 2022 in Review

Optiver Holding sold out of Trillium Therapeutics Inc. (TRIL) in Q1 2022, closing a stake of 1,049 shares — an estimated $18K sold.

Optiver Holding first reported a position in TRIL in Q3 2021 and held it in 2 quarters. The position peaked at $18K in Q4 2021. 0 funds tracked by Wall St. Rank hold TRIL as of Q1 2022.

Optiver Holding reported no remaining Trillium Therapeutics Inc. position as of Q1 2022 after selling out during the quarter.
Optiver Holding sold 1,049 Trillium Therapeutics Inc. shares in Q1 2022, an estimated $18K.
Optiver Holding first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 2 quarters.
Optiver Holding's Trillium Therapeutics Inc. position peaked at $18K in Q4 2021.
0 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q1 2022.

Based on Optiver Holding's 13F filing for Q1 2022, filed 16 May 2022.